Portfolio (Quarterly)
Guide ↗
Ally Bridge Group (NY) LLC
· CIK 0001822947| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | PRAXIS PRECISION MEDICINES I | — | 32,810.0 | $10.6M | 8.54% | NEW | — | $322.19 | — |
| 2 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 1,655,500.0 | $10.0M | 8.06% | NEW | — | $6.03 | -18.7% |
| 3 | — PUT | SOLENO THERAPEUTICS INC | — | 200,000.0 | $6.7M | 5.41% | NEW | — | $33.48 | — |
| 4 | — | SOLENO THERAPEUTICS INC | — | 200,000.0 | $6.7M | 5.41% | NEW | — | $33.48 | — |
| 5 | OVID | OVID THERAPEUTICS INC | Healthcare | 2,818,459.0 | $6.3M | 5.05% | NEW | — | $2.22 | +7.8% |
| 6 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 1,045,000.0 | $5.8M | 4.67% | NEW | — | $5.53 | +96.6% |
| 7 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 80,859.0 | $5.7M | 4.58% | NEW | — | $70.15 | -7.6% |
| 8 | — | SOLID BIOSCIENCES INC | — | 766,974.0 | $5.5M | 4.46% | NEW | — | $7.20 | — |
| 9 | CMPX CALL | COMPASS THERAPEUTICS INC | Healthcare | 1,000,000.0 | $5.3M | 4.27% | NEW | — | $5.29 | -64.2% |
| 10 | — | PROMIS NEUROSCIENCES INC | — | 414,219.0 | $5.3M | 4.25% | NEW | — | $12.70 | — |
| 11 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 161,000.0 | $5.1M | 4.10% | NEW | — | $31.50 | +4.2% |
| 12 | QURE CALL | UNIQURE NV | Healthcare | 300,000.0 | $4.9M | 3.96% | NEW | — | $16.35 | +50.5% |
| 13 | — | EUPRAXIA PHARMACEUTICALS INC | — | 660,375.0 | $4.8M | 3.86% | NEW | — | $7.24 | — |
| 14 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 900,000.0 | $4.2M | 3.42% | NEW | — | $4.70 | -20.9% |
| 15 | IVA | INVENTIVA SA | Healthcare | 745,300.0 | $4.1M | 3.34% | NEW | — | $5.55 | -6.5% |
| 16 | CATX | PERSPECTIVE THERAPEUTICS INC | Healthcare | 926,557.0 | $3.9M | 3.12% | NEW | — | $4.17 | -9.8% |
| 17 | ABVX | ABIVAX SA | Healthcare | 33,712.0 | $3.8M | 3.03% | NEW | — | $111.35 | +7.7% |
| 18 | ALMS | ALUMIS INC | Healthcare | 166,959.0 | $3.7M | 2.97% | NEW | — | $22.03 | +0.0% |
| 19 | URGN | UROGEN PHARMA LTD | Healthcare | 202,124.0 | $3.6M | 2.94% | NEW | — | $17.98 | +68.1% |
| 20 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 113,899.0 | $3.5M | 2.80% | NEW | — | $30.40 | -4.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%